NASDAQ:HSICHenry Schein Stock Price, Forecast & News

Henry Schein's stock was trading at $57.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, HSIC shares have increased by 16.2% and is now trading at $67.05.
View which stocks have been most impacted by COVID-19.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 3 sell ratings, 7 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Henry Schein.

Henry Schein is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Henry Schein.

Henry Schein, Inc. (NASDAQ:HSIC) posted its quarterly earnings data on Tuesday, May, 5th. The company reported $0.94 EPS for the quarter, topping the consensus estimate of $0.74 by $0.20. The business earned $2.43 billion during the quarter, compared to the consensus estimate of $2.32 billion. Henry Schein had a net margin of 6.35% and a return on equity of 11.51%. The company's quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.80 earnings per share.
View Henry Schein's earnings history.

Henry Schein shares split on the morning of Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

Henry Schein declared that its Board of Directors has approved a stock buyback program on Thursday, October 31st 2019, which authorizes the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 4.3% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's board of directors believes its stock is undervalued.

13 brokerages have issued twelve-month target prices for Henry Schein's shares. Their forecasts range from $50.00 to $80.00. On average, they anticipate Henry Schein's share price to reach $63.73 in the next twelve months. This suggests that the stock has a possible downside of 5.0%.
View analysts' price targets for Henry Schein.

Media headlines about HSIC stock have trended neutral this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Henry Schein earned a coverage optimism score of 0.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about Henry Schein.

Some companies that are related to Henry Schein include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), NVIDIA (NVDA), Micron Technology (MU), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Intel (INTC) and AT&T (T).

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Henry Schein's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Alecta Pensionsforsakring Omsesidigt (2.56%), New York State Common Retirement Fund (0.99%), Ardevora Asset Management LLP (0.53%), Swiss National Bank (0.52%), Sumitomo Mitsui Trust Holdings Inc. (0.42%) and PGGM Investments (0.30%). Company insiders that own Henry Schein stock include David Mckinley, E Dianne Rekow, Gerald A Benjamin, James P Breslawski, Michael S Ettinger, Paul Brons, Philip A Laskawy, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends for Henry Schein.

HSIC stock was sold by a variety of institutional investors in the last quarter, including Alecta Pensionsforsakring Omsesidigt, Prudential PLC, UBS Group AG, Davis R M Inc., Trexquant Investment LP, Arizona State Retirement System, New York State Common Retirement Fund, and Sumitomo Mitsui Trust Holdings Inc.. Company insiders that have sold Henry Schein company stock in the last year include Gerald A Benjamin, James P Breslawski, Michael S Ettinger, Paul Brons, Stanley M Bergman, Steven Paladino, and Walter Siegel.
View insider buying and selling activity for Henry Schein.

HSIC stock was bought by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Russell Investments Group Ltd., Strs Ohio, DNB Asset Management AS, Scout Investments Inc., First Trust Advisors LP, WINTON GROUP Ltd, and MERIAN GLOBAL INVESTORS UK Ltd.
View insider buying and selling activity for Henry Schein.

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of HSIC stock can currently be purchased for approximately $67.05.

Henry Schein has a market capitalization of $9.57 billion and generates $9.99 billion in revenue each year. The company earns $694.73 million in net income (profit) each year or $3.51 on an earnings per share basis. Henry Schein employs 19,000 workers across the globe.

The official website for Henry Schein is www.henryschein.com.

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]